CClinicalTrials.gg
TerminatedNCT04835701Updated Jul 15, 2022

Music as a Nonpharmacologic Approach to Pain Control With Intrauterine Device Placement

An interventional study of Music in Contraception, sponsored by Icahn School of Medicine at Mount Sinai. Terminated at 2 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-15.

Sponsored by Icahn School of Medicine at Mount Sinai · Not applicable, Interventional, and Diagnostic

Why this study was terminated
Limited staffing support to continue screening and enrollment process

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Dec 2020, registered Apr 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The intervention of this study is the addition of patient-selected music during IUD insertion procedure. Subjects randomized to the music group will choose 10 songs, which will be played during the procedure, from the time of positioning through completion of IUD insertion and speculum removal. Music may be played through a portable speaker in close proximity to the patient or through the patient's own headphones, if preferred. Music will be played at a low enough volume for subjects to hear standard anticipatory guidance during the procedure. Both control and music groups will otherwise undergo the same standard protocol for IUD insertion in an outpatient clinic setting. Total participation is predicted to last approximately 30 minutes.

Subjects in both control and intervention groups will undergo the same assessment of pain during IUD insertion using the 100-mm visual analog scale (VAS). This will be administered at 8 points during the procedure. All subjects will also answer the same 5-question satisfaction survey following IUD insertion. Pain scores will be measured and compared between music and control groups to assess the primary and secondary outcomes of this study.

Read the detailed description

This is a prospective, two-center, randomized controlled trial evaluating whether music reduces pain and improves satisfaction during IUD insertion. Computer-generated randomization assignments will allocate subjects to either music or standard protocol groups. 40 music and 40 control designations will be allocated to both sites, and all designations will be block-stratified into 10 blocks, each containing 4 controls and 4 intervention (music) subjects. This will ensure there are close to equal numbers of subjects in both groups if recruitment is halted before the minimum of 80 patients are enrolled. Assignments are available in a read-only document accessible by all co-investigators at the time of enrollment and randomization.

Subjects randomized to the music group will choose 10 songs, which will be played during the procedure, from the time of positioning through completion of IUD insertion and speculum removal. Music may be played through a portable speaker in close proximity to the patient or through the patient's own headphones, if preferred. Both control and music groups will otherwise undergo the same standard anticipatory guidance and protocol for IUD insertion in an outpatient clinic setting. Total participation is predicted to last approximately 30 minutes, as is standard for an appointment for IUD insertion. Study subjects will not interact with other participants.

Patients in both control and intervention groups will undergo intrauterine device (IUD) insertion. Pain will be assessed using a 100-mm visual analog scale (VAS) at 8 points during the procedure, including: (1) anticipated pain, (2) baseline pain prior to IUD insertion, (3) after speculum placement, (4) on tenaculum application, (5) on uterine sounding, (6) at IUD insertion, (7) after speculum removal, and (8) 5 minutes following the procedure. Patients will also answer a brief 5-question satisfaction survey following IUD insertion. Pain scores will be measured and compared between music and control groups to assess the primary and secondary outcomes of this study.

VAS scores will be recorded by the attending physician or co-investigator, as they will reliably note when each step of the procedure occurs and pain should be assessed. They will present the 100mm visual analog scale (VAS) to the patient at each of the 8 points of the procedure, and the patient will mark their pain score. Scores will be measured and documented by a single co-investigator to eliminate bias or differences in measurement.

VAS scores will be analyzed separately for each of the 8 distinct points described during the IUD insertion procedure. Differences between the intervention (music) and control groups will be assessed using a 0.05 level Wilcoxon ranksum test. A significant difference in pain will be noted if at least a 20 mm difference in VAS pain score exists between the two groups at any point of the procedure when VAS score is collected.

The aim of this study is to determine if music, chosen by the patient and played during IUD insertion, leads to lower pain scores and improved patient satisfaction with the procedure.

02

Conditions studied

  • Contraception

Keywords

  • Intrauterine device
  • IUD
  • Pain
  • Music
03

In context

Lead sponsor

Icahn School of Medicine at Mount Sinai is the lead sponsor of 764 studies on the registry; 181 are open to participants now.

Of its 121 completed or terminated interventional studies of FDA-regulated products, 82 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Provision of signed and dated informed consent form
  • Nulliparous adult females age 18 years or older (nulliparous is defined as no prior pregnancies greater than or equal to 20 weeks of gestation)
  • English-speaking patients
  • Undergoing insertion of a copper or levonorgestrel intrauterine device
  • Willing to comply with all study procedures

Exclusion criteria

Exclusion Criteria:

  • Non-English speaking patients
  • Patients with a support person in the room during IUD insertion
  • Patients desiring a paracervical block for analgesia
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
8 participants (actual)

Study arms

  • Experimental
    Music Intervention group

    Subjects randomized to the music group will choose 10 songs, which will be played during the procedure, from the time of positioning through completion of IUD insertion and speculum removal. Participants will otherwise undergo standard protocol for IUD insertion in an outpatient clinic setting. Total participation is predicted to last approximately 30 minutes.

    Behavioral: Music

  • No intervention
    Control group

    Participants to undergo same standard protocol for IUD insertion in an outpatient clinic setting. No music will be played during the procedure.

Interventions

  • BehavioralMusic

    Music may be played through a portable speaker in close proximity to the patient or through the patient's own headphones, if preferred. Music will be played at a low enough volume for subjects to hear standard anticipatory guidance during the procedure.

06

What researchers measure

Primary outcomes

  1. 100-mm visual analog scale (VAS)

    100-mm VAS total scale from 1-100 with higher score indicating more pain

    Time frame: Day 1, at time of IUD insertion

Secondary outcomes

  1. 100-mm visual analog scale (VAS)

    100-mm VAS total scale from 1-100 with higher score indicating more pain

    Time frame: Day 1, baseline prior to IUD insertion

  2. 100-mm visual analog scale (VAS)

    100-mm VAS total scale from 1-100 with higher score indicating more pain

    Time frame: Day 1, after speculum placement

  3. 100-mm visual analog scale (VAS)

    100-mm VAS total scale from 1-100 with higher score indicating more pain

    Time frame: Day 1, on tenaculum application

  4. 100-mm visual analog scale (VAS)

    100-mm VAS total scale from 1-100 with higher score indicating more pain

    Time frame: Day 1, on uterine sounding

  5. 100-mm visual analog scale (VAS)

    100-mm VAS total scale from 1-100 with higher score indicating more pain

    Time frame: Day 1, after speculum removal

  6. 100-mm visual analog scale (VAS)

    100-mm VAS total scale from 1-100 with higher score indicating more pain

    Time frame: Day 1, 5 minutes following the procedure

  7. Patient Satisfaction Survey

    Patient Satisfaction Survey consists of 5-question administered post-procedure. Full scale from 1 to 5, with higher score indicating higher satisfaction.

    Time frame: Day 1, post procedure at 30 minutes

07

Study locations

2 sites
  • Mount Sinai Beth Israel
    New York, New York 10003, United States
  • Mount Sinai West
    New York, New York 10019, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 15, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04835701
Lead sponsor
Icahn School of Medicine at Mount Sinai
Responsible party
Melissa Lozano (Assistant Professor, Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai) — Principal investigator
First posted
Apr 8, 2021
Start date
Dec 14, 2020
Primary completion
Nov 16, 2021
Completion
Nov 16, 2021
Last update
Jul 15, 2022

Study contacts

Neha R Bhardwaj, MD
principal investigator · Icahn School of Medicine at Mount Sinai

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion